Shigeyuki Nakano

Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles, CYP2C19m1 in exon 5 and CYP2C19m2 in exon 4, in Japanese subjects*

Ichiro Ieiri, Takahiro Kubota, Akinori Urae et al. · Clinical Pharmacology & Therapeutics · 1996 · 114 citations

Veterinary Medicine, Pharmacokinetics, Pharmacology +15

Cell Cycle-Dependent Chronotoxicity of Irinotecan Hydrochloride in Mice

Shigehiro Ohdo, Tomoko Makinosumi, Takashi Ishizaki et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 97 citations

Medicine, Pharmacology, Toxicology +16

Efficacy and safety of iguratimod compared with placebo and salazosulfapyridine in active rheumatoid arthritis: a controlled, multicenter, double-blind, parallel-group study

Masako Hara, Tohru Abe, Sachiko Sugawara et al. · Modern Rheumatology · 2007 · 87 citations

Medicine, Pharmacology, Pharmacotherapy +14

Determination of ciprofloxacin in plasma and urine by HPLC with ultraviolet detection

Marika Kamberi, Kimiko Tsutsumi, Tsutomu Kotegawa et al. · Clinical Chemistry · 1998 · 79 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Influences of Urinary pH on Ciprofloxacin Pharmacokinetics in Humans and Antimicrobial Activity In Vitro versus Those of Sparfloxacin

Marika Kamberi, Kimiko Tsutsumi, Tsutomu Kotegawa et al. · Antimicrobial Agents and Chemotherapy · 1999 · 68 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14